Positive Response Observed in HS Patients Having Failed Anti-TNF Therapy Treated with Lutikizumab
These phase 2 data on hidradenitis suppurativa patients highlight new information on the use of lutikizumab as a treatment alternative.
Alexab Kimball Roopal Thakkar Harvard Medical School Beth Israel Deaconess Medical Center Numeric Rating Scale Hidradenitis Suppurativa
Source: hcplive.com